Lusis Biosciences

That’s a wrap on NILA 2025! We had an incredible time at the National Independent Laboratory Association (NILA) Forum, connecting with lab leaders who are shaping the future of molecular science. Here are some key takeaways:? ? Financial Efficiency – Labs are looking to optimize costs without compromising on quality. Our high-performance qPCR solutions enable cost-effective multiplexing, reducing reactions while increasing throughput.? ? Total Solutions Partnership – More than just reagents, Lusis delivers comprehensive technical support, from assay development to implementation, ensuring seamless integration into existing workflows.? ? Comprehensive Portfolio – From respiratory, GI, UTI, STI, wound, AMR, and bloodborne pathogen detection, our broad qPCR panels meet the evolving needs of high-complexity labs. A huge thank you to NILA and everyone who stopped by to chat—your insights and discussions help us further drive innovation! ?? Missed us at the event? Let’s continue the conversation. Contact us at [email protected] to learn how Lusis can support your lab. #NILA2025 #LabInnovation #qPCR #MolecularScience #AMR #ClinicalLab

Heading to the National Independent Laboratory Association (NILA) Forum this weekend? So are we! Join us Feb 28 – Mar 2 in San Antonio, Texas as we connect with industry leaders to discuss our smarter qPCR solutions for infectious disease detection: ?? More Insights, Less Effort – Detect more with fewer reactions & faster turnaround ?? Reliable & Flexible – Built-in QC and versatile pathogen & AMR workflows ?? Cost-Effective & Scalable – Optimized for efficiency, with expert support always included Let’s talk about how we can help your lab streamline workflows and drive results! Schedule a meeting with us by emailing [email protected]. #NILA2025 #qPCR #LabInnovation #InfectiousDisease #AMR

Antimicrobial resistance (AMR) continues to pose a significant challenge in treating urinary tract infections. The U.S. Food and Drug Administration (FDA) has recently approved a new oral sulopenem, Orlynvah, for treating uncomplicated urinary tract infections in adult women with limited or no alternative oral antibacterial treatment options. This marks the first approval of an oral penem antibiotic in the U.S., offering a new option for patients facing antibiotic resistance. The approval of this treatment highlights the healthcare industry's response to the rising threat of antimicrobial resistance (AMR) in UTIs. At Lusis, we're contributing to this fight with the launch of VeraPoint Urinary Max and VeraPoint AMR Max - comprehensive solutions for UTI and AMR detection. By enabling multiplexing, comprehensive target coverage (29 UTI-causing pathogens and 18 resistance genes), and modular flexibility, VeraPoint Urinary Max and VeraPoint AMR Max empower labs to gain deeper insights into resistance patterns while streamlining workflows. Together, therapeutic advancements like this and research tools like VeraPoint Urinary Max and AMR Max are paving the way for better understanding, treatment, and management of UTIs and AMR. Learn more about VeraPoint Urinary Max and VeraPoint AMR Max at https://hubs.la/Q030hhtr0. #Orlynvah #AMR #UTI #AntibioticResistance #AntimicrobialResistance #qPCR #Innovation

We're excited to announce the launch VeraPoint Urinary Max and VeraPoint AMR Max - innovative qPCR panels designed to bring efficiency, precision, and flexibility to laboratory workflows. What sets Urinary Max and AMR Max apart? ?? Comprehensive Target Range: Identify 29 of the most common pathogens implicated in UTIs and 18 AMR genes. ?? Multiplexing: Detect up to three targets per well, reducing sample requirements and lab costs while streamlining workflows. ?? Internal Controls: Built into every mix to validate sample integrity and reagent performance for confidence in every run. ?? Modular Flexibility: Small, medium, or large panel options with AMR and species-specific Candida add-ons for expanded detection. ?? Delivering Value Without Compromise: Optimized workflows balance performance and cost-efficiency to achieve more with less. Learn more about how VeraPoint UTI and AMR reagents can enhance your lab’s capabilities at https://hubs.la/Q02_8SlD0. For Research Use Only. Not intended for diagnostic applications. #MolecularResearch #UrinaryTractInfections #UTI #AntimicrobialResistance #LabSolutions

?? Equip Your Lab for the Respiratory Season with Lusis's VeraPoint Reagents As we enter respiratory season, labs around the world are focusing on preparing for the potential surge in respiratory infections. Need more reliable, cost-effective tools optimized for pathogen detection? ?? VeraPoint Respiratory Reagents are designed for: ? Comprehensive coverage of respiratory pathogens, including COVID, Flu A/B, RSV, and more. ? Rapid and precise identification of pathogens. ? Efficient and reliable performance to streamline research workflows. ?? Discover more about our products and how they can support your lab this season. Get a quote by emailing us at [email protected]. #FluSeason #RespiratorySeason #COVID #qPCR

The Lusis Team had a great time at the #ADLM Clinical Lab Expo in Chicago. At our booth, we showcased the latest in molecular science, including our VeraPoint qPCR reagents and Q-Vera qPCR instruments. These innovations are designed to meet the evolving needs of laboratories by offering accuracy, affordability, and scalability across a wide range of infectious disease applications. Whether you stopped by to learn more about our products, take an alcohol tolerance test, or snag one of our virus plushies, we're grateful for your time and interest. Let's continue the conversation! Email us at [email protected] to learn more about how Lusis products and services can support your needs. #ADLM2024 #ClinicalLabExpo #InfectiousDiseases #Innovation #PCR #LabTech

Lusis is so excited to be attending #ADLM2024 in Chicago this week. Here's what to expect from us at booth #637: ?? VeraPoint Reagents: Explore our 30 key qPCR products and hundreds of additional targets for infectious disease applications. ?? Q-Vera Instruments: Discover how our qPCR instruments can optimize your molecular laboratory workflow. ?? Complimentary Alcohol Tolerance Testing: Get a fun report about your body's alcohol tolerance and genetic makeup with our easy test. To schedule a meeting, email us at [email protected]. See you at McCormick Place!

Introducing Lusis. We’re on a mission to make molecular science accessible for everyone. Our reagents and instruments focus on infectious disease research applications. With an emphasis on world-class support, we engineer our solutions to meet the needs of today’s laboratories – accuracy, affordability, scalability, and rapid turn-around time. Learn more at lusisbio.com.